Importance of cellular immunity link for efficiency of replacement therapy in common variable immune deficiency
Lifetime use of IgG replacement therapy is the standard of CVID treatment. However, full control over stabilization of chronic infection loci is not always achieved, even if this therapy is continuously applied. The purpose of this study was to carry out comparative analysis of changes in cellul...
Enregistré dans:
Auteurs principaux: | L. P. Sizyakina, I. I. Andreeva, D. I. Danilova |
---|---|
Format: | article |
Langue: | RU |
Publié: |
SPb RAACI
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f0bad738bf3d4c41a2eb983efc55e517 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Republican registry of primary immune deficiencies in the chuvash republic and description of postvaccinal immunity disorders in a pregnant patient with common variable immune deficiency
par: L. M. Karzakova, et autres
Publié: (2021) -
HUMORAL AND CELLULAR IMMUNITY FACTORS IN MYOCARDIAL INFARCTION
par: V. I. Seledtsov, et autres
Publié: (2014) -
SELECTED CELLULAR IMMUNITY INDICATORS IN DIAGNOSTICS OF ACUTE MESENTERIAL ISCHEMIA
par: Z. A. Artamonova, et autres
Publié: (2017) -
Humoral and cellular immunity to measles and rubella virus antigens in healthy subjects
par: M. A. Smerdova, et autres
Publié: (2019) -
Cellular immune response in convalescents from Ixodes tick-borne borreliosis
par: T. S. Zaporozhets, et autres
Publié: (2020)